-+ 0.00%
-+ 0.00%
-+ 0.00%

MINOVIA THERAPEUTICS ANNOUNCES INTERIM DATA FROM PHASE 2 TRIAL IN PEARSON SYNDROME DEMONSTRATING NO TREATMENT-RELATED SERIOUS ADVERSE EVENTS AND PRELIMINARY SIGNAL FOR EFFICACY MEASURED BY GROWTH

Reuters·07/24/2025 12:15:00

Please log in to view news